Mark J Amsbaugh1, Mehran Yusuf2, Elizabeth Cash3, Craig Silverman2, Elizabeth Wilson3, Jeffrey Bumpous3, Kevin Potts3, Cesar Perez4, Robert Bert5, Rebecca Redman4, Neal Dunlap2. 1. Department of Radiation Oncology, University of Louisville, Louisville, Kentucky. Electronic address: mjamsb01@louisville.edu. 2. Department of Radiation Oncology, University of Louisville, Louisville, Kentucky. 3. Department of Otolaryngology, University of Louisville, Louisville, Kentucky. 4. Division of Medical Oncology, Department of Medicine, University of Louisville, Louisville, Kentucky. 5. Department of Diagnostic Radiology, University of Louisville, Louisville, Kentucky.
Abstract
PURPOSE/OBJECTIVE(S): To investigate the factors contributing to the clinical presentation of oropharyngeal squamous cell carcinoma (OPSCC) in the era of risk stratification using human papilloma virus (HPV) and smoking status. METHODS AND MATERIALS: All patients with OPSCC presenting to our institutional multidisciplinary clinic from January 2009 to June 2015 were reviewed from a prospective database. The patients were grouped as being at low risk, intermediate risk, and high risk in the manner described by Ang et al. Variance in clinical presentation was examined using χ(2), Kruskal-Wallis, Mann-Whitney, and logistic regression analyses. RESULTS: The rates of HPV/p16 positivity (P<.001), never-smoking (P=.016), and cervical lymph node metastases (P=.023) were significantly higher for patients with OPSCC of the tonsil, base of tongue (BOT), or vallecula subsites when compared with pharyngeal wall or palate subsites. Low-risk patients with tonsil, base of tongue, or vallecula primary tumors presented with nodal stage N2a at a much higher than expected frequency (P=.007), and high-risk patients presented with tumor stage T4 at a much higher than expected frequency (P=.003). Patients with BOT primary tumors who were never-smokers were less likely to have clinically involved ipsilateral neck disease than were former smokers (odds ratio 1.8; P=.038). The distribution of cervical lymph node metastases was not associated with HPV/p16 positivity, risk group, or subsite. When these data were compared with those in historical series, no significant differences were seen in the patterns of cervical lymph node metastases for patients with OPSCC. CONCLUSIONS: For patients with OPSCC differences in HPV status, smoking history and anatomic subsite were associated with differences in clinical presentation but not with distribution of cervical lymph node metastases. Historical series describing the patterns of cervical lymph node metastases in patients with OPSCC remain clinically relevant.
PURPOSE/OBJECTIVE(S): To investigate the factors contributing to the clinical presentation of oropharyngeal squamous cell carcinoma (OPSCC) in the era of risk stratification using human papilloma virus (HPV) and smoking status. METHODS AND MATERIALS: All patients with OPSCC presenting to our institutional multidisciplinary clinic from January 2009 to June 2015 were reviewed from a prospective database. The patients were grouped as being at low risk, intermediate risk, and high risk in the manner described by Ang et al. Variance in clinical presentation was examined using χ(2), Kruskal-Wallis, Mann-Whitney, and logistic regression analyses. RESULTS: The rates of HPV/p16 positivity (P<.001), never-smoking (P=.016), and cervical lymph node metastases (P=.023) were significantly higher for patients with OPSCC of the tonsil, base of tongue (BOT), or vallecula subsites when compared with pharyngeal wall or palate subsites. Low-risk patients with tonsil, base of tongue, or vallecula primary tumors presented with nodal stage N2a at a much higher than expected frequency (P=.007), and high-risk patients presented with tumor stage T4 at a much higher than expected frequency (P=.003). Patients with BOT primary tumors who were never-smokers were less likely to have clinically involved ipsilateral neck disease than were former smokers (odds ratio 1.8; P=.038). The distribution of cervical lymph node metastases was not associated with HPV/p16 positivity, risk group, or subsite. When these data were compared with those in historical series, no significant differences were seen in the patterns of cervical lymph node metastases for patients with OPSCC. CONCLUSIONS: For patients with OPSCC differences in HPV status, smoking history and anatomic subsite were associated with differences in clinical presentation but not with distribution of cervical lymph node metastases. Historical series describing the patterns of cervical lymph node metastases in patients with OPSCC remain clinically relevant.
Authors: Aisling S Last; Patrik Pipkorn; Stephanie Chen; Dorina Kallogjeri; Joseph Zenga; Jason T Rich; Randal Paniello; Jose Zevallos; Rebecca Chernock; Douglas Adkins; Peter Oppelt; Hiram Gay; Mackenzie Daly; Wade Thorstad; Ryan S Jackson Journal: JAMA Otolaryngol Head Neck Surg Date: 2020-01-01 Impact factor: 6.223
Authors: Carlos Miguel Chiesa-Estomba; Juan David Urazan; Cammaroto Giovanni; Mannelli Giuditta; Molteni Gabriele; Dallari Virginia; R Lechien Jerome; Miguel Mayo-Yanez; José Ángel González-García; Jon Alexander Sistiaga-Suarez; Tucciarone Manuel; Ayad Tareck; Meccariello Giuseppe Journal: Eur Arch Otorhinolaryngol Date: 2022-09-14 Impact factor: 3.236
Authors: Masanari G Kato; Chung-Hwan Baek; Pankaj Chaturvedi; Richard Gallagher; Luiz P Kowalski; C René Leemans; Saman Warnakulasuriya; Shaun A Nguyen; Terry A Day Journal: World J Otorhinolaryngol Head Neck Surg Date: 2020-03-06
Authors: Frans J Mulder; Damiana D C G Pierssens; Laura W J Baijens; Bernd Kremer; Ernst-Jan M Speel Journal: Head Neck Date: 2020-10-23 Impact factor: 3.147